Data evaluating safety and injection feasibility from a Phase 1 study of JNJ-1900 (NBTXR3) in combination nivolumab or ...

Data evaluating safety and early signals of efficacy including updated local PFS from the completed dose escalation part of a Phase 1 study of re-irradiation with JNJ-1900 (NBTXR3) for patients ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming ...

IT’S hard to imagine a time when the word ‘Ozempic’ wasn’t part of our vocabulary.  For years, celebs have embraced the ...

What you need to know about opioid overdose reversal drug nalmefene’s risks, effectiveness and clinical concerns ...

Remission persisted through 104 weeks for most patients with eosinophilic granulomatosis with polyangiitis who used ...

And looking at the statistics regarding unplanned pregnancies, you’d think birth control is hard to get ahold of in Mexico.

A decade after the worst of the virus’ 40 outbreaks killed 11,300 people, individuals who still bear its physical and mental ...

Patients with hereditary angioedema whose attacks impacted their larynx experienced on-demand relief within 1.29 hours with ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, ...

Of course, the antagonist isn't about to get his hands dirty with that matter, so he tasks Banner with building an army to take the Dutton ranch by force. Those left teetering at the edge of their ...